R&D Partner Content The Brand-New Peptide Based Therapeutics Summit - Boston, MA First event dedicated to designing, synthesising & identifying the optimal peptide-based drugs
News Astellas builds in protein degraders with PeptiDream deal Astellas has made another move into the area of protein degrader drugs, announcing its second partnership in the category in the space of two months.
Partner Content Partner Content Ipsen presents on oral peptides innovations, advances and de... Ipsen presents on oral peptides innovations & delivery
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.